文献速递胃肠外科围术期管理与 ERAS

肥胖对胃癌腹腔镜辅助远端胃切除术短期与长期结局的影响

Impact of obesity on short- and long-term outcomes of laparoscopy assisted distal gastrectomy for gastric cancer.
PubMed 文献 · Surg Endosc · 2017-06-27

肥胖组手术时间与估计出血量更多、淋巴结检出数更少,但术后并发症率与住院时间无差异;肥胖组5年总生存率和疾病特异性生存率均显著更低。

要点

  • 肥胖(BMI≥25)不增加LADG术后并发症率与住院时间。
  • 肥胖组手术时间更长、出血更多、淋巴结检出数更少。
  • 肥胖与胃癌LADG术后5年生存率更低相关。

核心结论

  • 肥胖患者行LADG的术后短期结果与非肥胖患者相当,但肥胖可能是胃癌的不良预后因素。

研究设计与样本

  • 按BMI分为肥胖组(BMI≥25)与非肥胖组(BMI<25),比较两组特征、围手术期与长期结局。

主要发现

  • 两组在年龄、性别、ASA评分、合并症及病理分期上无差异。
  • 肥胖组手术时间265±46.6 vs 244±55.6 min(P=0.007),估计出血量113±101.4 vs 66.5±95.2 ml(P=0.007)。
  • 肥胖组淋巴结检出数38±23.7 vs 47.5±24.3(P=0.004)。
  • 术后并发症率20% vs 17%(P=0.688),术后住院时间9±8.5 vs 9±5.1天(P=0.283),均无差异。
  • 肥胖组5年总生存率67.6% vs 90.3%(P=0.036),5年疾病特异性生存率72.7% vs 94.9%(P=0.015),均显著更低。

临床怎么用

  • 肥胖患者行LADG短期安全性可接受,但需注意手术时间延长、出血增多及淋巴结检出数减少。
  • 对肥胖胃癌患者应关注长期预后,可能需要更严密随访。

局限性

  • 回顾性单中心研究,样本量243例,可能存在选择偏倚与混杂因素。
  • 肥胖定义采用BMI≥25,未区分肥胖程度及体脂分布。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopy assisted distal gastrectomy (LADG) for gastric cancer has been rapidly adopted for the treatment of both early and advanced gastric cancers which need lymph node dissection, but remains difficult procedure, especially in patients with obesity. We evaluated the impact of obesity on short- and long-term outcomes of LADG for gastric cancer. METHODS: We retrospectively investigated 243 patients who underwent LADG for gastric cancer between January 2007 and December 2014. The patients were classified based on their body mass index (BMI) into the Obese (BMI ≥ 25) and Non-Obese (BMI < 25) Groups. Patient characteristics, clinicopathologic and operative findings, and short- and long-term outcomes were investigated and compared between the groups. RESULTS: The groups did not differ in age, sex, American Society of Anesthesiologists score, the presence of comorbidities, or pathologic stage. Operative time (265 ± 46.6 vs. 244 ± 55.6 min; P = 0.007) and estimated blood loss (113 ± 101.4 vs. 66.5 ± 95.2 ml; P = 0.007) were greater in the Obese Group. Fewer lymph nodes were retrieved in the Obese Group (38 ± 23.7 vs. 47.5 ± 24.3; P = 0.004). No differences were evident in postoperative complication rate (20% vs. 17%; P = 0.688) or the duration of postoperative hospital stay (9 ± 8.5 vs. 9 ± 5.1 days; P = 0.283) between the two groups. In the Obese Group, the 5-year overall survival rate was significantly lower than in the Non-Obese Group (67.6% vs. 90.3%; P = 0.036). Furthermore, 5-year disease-specific survival was significantly lower in the Obese Group than in the Non-Obese Group (72.7% vs. 94.9%; P = 0.015). CONCLUSIONS: LADG in patients with obesity could be performed as safe as in patients without obesity, with comparable postoperative results. But obesity may be a poor prognostic factor in gastric cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Shimada S, Sawada N, Ishiyama Y, et al. Impact of obesity on short- and long-term outcomes of laparoscopy assisted distal gastrectomy for gastric cancer. Surg Endosc. 2017. PMID: 28656334. doi:10.1007/s00464-017-5684-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。